If administered early, gene therapy has the potential to change the medical history of children born with metachromatic leukodystrophy (MLD), a rare and lethal neurodegenerative disease of genetic ...

Some $2 million in the governor's supplemental budget proposal could help save lives. Last month, WBAL-TV 11 News introduced ...

The FDA approved atidarsagene autotemcel (arsa-cel; Lenmeldy), the first gene therapy to treat children with pre-symptomatic late infantile, pre-symptomatic early juvenile, or early symptomatic early ...

Please provide your email address to receive an email when new articles are posted on . Metachromatic leukodystrophy is an incurable rare genetic disease. At 5 years of age, 71% of children given ...

Finding showed treatment with Lenmeldy significantly extended severe motor impairment-free survival in children with PSLI MLD compared with untreated natural history children. The Food and Drug ...

MINDY BASARA IN TODAY’S MEDICAL ALERT, METACHROMATIC LEUKODYSTROPHY IS ONE OF MANY RARE GENETIC DISEASES. IT’S FATAL. HOWEVER, THERE IS A NEW TREATMENT FOR IT IF DETECTED EARLY THROUGH A BLOOD TEST AT ...

BEDFORD, Mass., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Homology Medicines, Inc. (Nasdaq: FIXX), a genetic medicines company, announced today the details of HMI-204, its optimized, in vivo, one-time gene ...

BOISE, Idaho — Piper Morse and her son Grayson have been dreaming of a special place where they could get outside and enjoy time together. Make-a-Wish Idaho was able to step in and make that dream a ...

TUBB4a leukodystrophy is an "incurable genetic condition" that affects one in 1,663 births, according to the Cleveland Clinic. First identified in 2014, it makes up a small percentage of the 50 rare ...